Cordyceps Sunshine Biotech Holdings RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Cordyceps Sunshine Biotech Holdings (RAJAF) Receivables - Net (2021 - 2024)

Cordyceps Sunshine Biotech Holdings (RAJAF) posted quarterly Receivables - Net of $21869.0 for Q3 2023, down 93.89% quarter-over-quarter from $358006.0 in Q4 2021.

Cordyceps Sunshine Biotech Holdings (RAJAF) Receivables - Net (2021 - 2024) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Receivables - Net history runs 2 years deep, the most recent figure standing at $21869.0 for Q3 2023.

  • In Q3 2023, Receivables - Net changed N/A year-over-year to $21869.0; the TTM figure through Sep 2023 stood at $21869.0 (changed N/A YoY), while the FY2024 annual figure was $305.0, changed N/A from the prior year.
  • Receivables - Net for Q3 2023 stood at $21869.0, down from $358006.0 in the prior quarter.
  • The five-year high for Receivables - Net was $358006.0 in Q4 2021, with the low at $21869.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Kraft Heinz 30.37 Bn 27.69 Bn 2.03 Bn
2 General Mills 21.49 Bn 21.03 Bn 1.60 Bn
3 Mccormick 14.93 Bn 14.60 Bn 778.20 Mn
4 Jbs 14.80 Bn 11.34 Bn 4.91 Bn
5 J M Smucker 13.21 Bn 13.15 Bn 862.10 Mn
6 Hormel Foods 13.14 Bn 12.28 Bn 518.51 Mn
7 Magnum Ice Cream 12.22 Bn 11.50 Bn -
8 Darling Ingredients 10.40 Bn 10.24 Bn 503.37 Mn
9 Smithfield Foods 8.75 Bn 7.40 Bn 478.00 Mn
10 Cordyceps Sunshine Biotech Holdings 1.02 Bn 1.02 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 305.00
Dec 31, 2024 305.00
Sep 30, 2023 21,869.00
Sep 30, 2023 21,869.00
Dec 31, 2021 358,006.00
Dec 31, 2021 358,006.00